Elias A. Zerhouni, MD was appointed President of OPKO Health and Vice Chairman of the Board on May 9, 2022. Dr. Zerhouni had been the Chairman and is the Co-founder of ModeX Therapeutics Inc., a start-up biotechnology company focused on multi specific-immune therapies for cancer and viral diseases, from October 2020 until its acquisition by OPKO in May 2022. He is a physician scientist in Imaging and Biomedical Engineering. He served as President of Global Research & Development and Executive Vice President of Sanofi (NASDAQ: SNY) from 2010-2018, as Senior Fellow for global health research at the Bill and Melinda Gates Foundation from 2009-2010 and as Presidential U.S. envoy for science and technology from 2009-2010. He was Director of the U.S. National Institutes of Health from 2002-2008, Executive Vice Dean and Dean for research at the Johns Hopkins School of Medicine from 1996-2002, and Professor of Radiology and Biomedical Engineering and chair of the department of Radiological Sciences and is now professor emeritus of Johns Hopkins University. Dr. Zerhouni was elected to the National Academy of Medicine and to the National Academy of Engineering. He serves on the boards of Lasker Foundation, Foundation for National Institutes of Health and Research!America. He received the 2017 Scripps Executive of the Year Award for the pharmaceutical industry and the French Legion of Honor in 2008. Since 2009, Dr. Zerhouni has served as a director of the publicly traded Danaher Corporation (NYSE:DHR). Since 2019, he has also served as a director of B-FLEXION Capital.